[
    [
        {
            "time": "2019-11-11",
            "original_text": "格隆汇港股聚焦(11.11)︱上海电气拟斥资不超29.59亿元控股赢合科技 绿地香港前10月销售额升37.7%至385亿元",
            "features": {
                "keywords": [
                    "上海电气",
                    "斥资",
                    "控股",
                    "赢合科技",
                    "绿地香港",
                    "销售额",
                    "增长"
                ],
                "sentiment_score": 0.75,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "工业设备",
                    "房地产"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "none"
            },
            "scores": {
                "News_content": "格隆汇港股聚焦(11.11)︱上海电气拟斥资不超29.59亿元控股赢合科技 绿地香港前10月销售额升37.7%至385亿元",
                "Correlation": 8,
                "Sentiment": 7,
                "Importance": 9,
                "Impact": 8,
                "Duration": 7,
                "Entity_Density": 6,
                "Market_Scope": 5,
                "Time_Proximity": 9,
                "Headline_Structure": 9,
                "Source_Recency": 9
            }
        },
        {
            "time": "2019-11-11",
            "original_text": "【西部医药吴文华】2019年医药行业三季报综述：医药整体稳健增长，子行业分化较为明显",
            "features": {
                "keywords": [
                    "医药行业",
                    "三季报",
                    "稳健增长",
                    "子行业分化"
                ],
                "sentiment_score": 0.6,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "neutral",
                "affected_by_time_series": "true",
                "ts_effect_direction": "mixed"
            },
            "scores": {
                "News_content": "【西部医药吴文华】2019年医药行业三季报综述：医药整体稳健增长，子行业分化较为明显",
                "Correlation": 5,
                "Sentiment": 6,
                "Importance": 6,
                "Impact": 5,
                "Duration": 6,
                "Entity_Density": 3,
                "Market_Scope": 8,
                "Time_Proximity": 7,
                "Headline_Structure": 7,
                "Source_Recency": 7
            }
        },
        {
            "time": "2019-11-11",
            "original_text": "上海医药(601607.SH)：2019年股票期权激励计划获上海国资委批复",
            "features": {
                "keywords": [
                    "上海医药",
                    "股票期权",
                    "激励计划",
                    "国资委批复"
                ],
                "sentiment_score": 0.8,
                "policy_related": "true",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "none"
            },
            "scores": {
                "News_content": "上海医药(601607.SH)：2019年股票期权激励计划获上海国资委批复",
                "Correlation": 9,
                "Sentiment": 8,
                "Importance": 8,
                "Impact": 7,
                "Duration": 7,
                "Entity_Density": 9,
                "Market_Scope": 4,
                "Time_Proximity": 8,
                "Headline_Structure": 6,
                "Source_Recency": 8
            }
        },
        {
            "time": "2019-11-11",
            "original_text": "11月11日上市公司晚间公告速递",
            "features": {
                "keywords": [
                    "上市公司",
                    "晚间公告",
                    "速递"
                ],
                "sentiment_score": 0.5,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [],
                "causal_factor": "false",
                "causal_impact": "none",
                "affected_by_time_series": "false",
                "ts_effect_direction": "none"
            },
            "scores": {
                "News_content": "11月11日上市公司晚间公告速递",
                "Correlation": 4,
                "Sentiment": 5,
                "Importance": 4,
                "Impact": 4,
                "Duration": 5,
                "Entity_Density": 3,
                "Market_Scope": 6,
                "Time_Proximity": 9,
                "Headline_Structure": 8,
                "Source_Recency": 9
            }
        },
        {
            "time": "2019-11-11",
            "original_text": "上海医药：股票期权激励计划获上海市国资委批复",
            "features": {
                "keywords": [
                    "上海医药",
                    "股票期权",
                    "激励计划",
                    "国资委批复"
                ],
                "sentiment_score": 0.8,
                "policy_related": "true",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "none"
            },
            "scores": {
                "News_content": "上海医药：股票期权激励计划获上海市国资委批复",
                "Correlation": 9,
                "Sentiment": 8,
                "Importance": 8,
                "Impact": 7,
                "Duration": 7,
                "Entity_Density": 9,
                "Market_Scope": 4,
                "Time_Proximity": 8,
                "Headline_Structure": 6,
                "Source_Recency": 8
            }
        },
        {
            "time": "2019-11-11",
            "original_text": "上海医药(02607.HK)2019年股票期权激励计划获上海国资委批复",
            "features": {
                "keywords": [
                    "上海医药",
                    "股票期权",
                    "激励计划",
                    "国资委批复"
                ],
                "sentiment_score": 0.8,
                "policy_related": "true",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "none"
            },
            "scores": {
                "News_content": "上海医药(02607.HK)2019年股票期权激励计划获上海国资委批复",
                "Correlation": 9,
                "Sentiment": 8,
                "Importance": 8,
                "Impact": 7,
                "Duration": 7,
                "Entity_Density": 9,
                "Market_Scope": 4,
                "Time_Proximity": 8,
                "Headline_Structure": 6,
                "Source_Recency": 8
            }
        }
    ]
]